Characteristics | Equation 1: binary (implementation) AMEa,b (SE) | Equation 2: positives (program reach) AMEa (SE) |
---|---|---|
Key independent variables | ||
 Implementation climated | 2.65 (1.85 × 103)c*** | 5.05 (1.5)** |
 Innovation-values fitd | 2.17 (1.041 × 102)* | 11.79 (3.170)*** |
Patient needs and resources | ||
 Rural location | −0.77 (0.016) | − 12.81 (4.658)** |
 Clinical factors | −0.04 (3 × 104) | − 0.14 (0.11) |
 Social factors | −0.06 (3 × 104) | − 0.10 (0.10) |
 340B participation | 5.70 (3.50 × 102)* | 12.80 (5.760)* |
 Proportion of high-risk patients | 0.00 (0.00)* | – |
 Log of high-risk patients | – | (exposure) |
Available resources | ||
 Presence of a clinical pharmacist | 9.86 (4.75 × 102)* | 32.33 (10.670)*** |
 Total number of staff | − 0.31 (2.6 × 103) | − 1.98 (0.550)*** |
 Presence of pharmacy student or resident | 6.86 (6.37 × 102) | 14.55 (7.273) |
Access to knowledge about the intervention | ||
 Amount of experience with NC-CPESN (months) | 0.43 (1.3 × 103)** | 1.57 (0.610)*** |
 Past performance with NC-CPESN | 0.46 (1.3 × 102)*** | 0.10 (0.031)*** |
 Participation in Medicare Part D MTM | 18.73 (6.246 × 102)** | 28.05 (13.83)* |
Structural characteristics | ||
 Independent pharmacy | 4.14 (2.02 × 102)* | 0.43 (5.6) |
 Low prescription volume | 1.08 (0.032) | 7.23 (7.21) |
 Established pharmacy | 2.02 (0.015) | 4.14 (7.46) |
Alpha | – | 0.56 (7.08 × 102)** |
Constant | − 21.04 (4.79)*** | − 14.03 (1.383)*** |
Observations | 180 | 104 |